BioDiem proves Bird Flu vaccine works
US - BioDiem Limited (BDM) today announced that Pre-clinical test results have shown a positive potential for a new avian flu vaccine. The Australian pharmaceutical development company, together with colleagues from the US Centre for Disease Control (“CDC”) has produced an effective, experimental live attenuated, reassortant influenza vaccine.
15 April 2004
1 minute read
